Insider trade

Officer received an award of 3,000 LH derivative securities

Traded Sep 1, 2026 · Filed Sep 3, 2026

LabcorpLH

3,000
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 1, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 3, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000920148-26-000190
Filed / recorded

Sep 3, 2026, 12:07 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

LABCORP HOLDINGS INC.

Issuer CIK

920148

Ticker

LH

Reporting person

Brian J Caveney

Relationship

Officer

Officer title

EVP, Pres of BLS, CMO & CSO

Security

Restricted Stock Unit

Table

Derivative (Table II)

Transaction date

Sep 1, 2026

Transaction code

A

Shares / units

3,000

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

7,170

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.